Entity usage

Jump to navigation Jump to search

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 50 results in range #151 to #200.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5: Title
  2. Hua F, et al. Gastroenterology (2019) cited as Ref 621 in DOI: 10.1038/s41392-020-0110-5: Title
  3. Fu L, et al. Gut (2011) cited as Ref 620 in DOI: 10.1038/s41392-020-0110-5: Title
  4. Kraggerud SM, et al. Endocr. Rev. (2013) cited as Ref 619 in DOI: 10.1038/s41392-020-0110-5: Title
  5. Pohl SG, et al. Oncogenesis (2017) cited as Ref 618 in DOI: 10.1038/s41392-020-0110-5: Title
  6. Lauth M, et al. Proc. Natl Acad. Sci. USA (2007) cited as Ref 617 in DOI: 10.1038/s41392-020-0110-5: Title
  7. List A, et al. Leukemia (2003) cited as Ref 616 in DOI: 10.1038/s41392-020-0110-5: Title
  8. Cortes JE, et al. Leukemia (2019) cited as Ref 615 in DOI: 10.1038/s41392-020-0110-5: Title
  9. Cortes JE, et al. Am. J. Hematol. (2018) cited as Ref 614 in DOI: 10.1038/s41392-020-0110-5: Title
  10. Magnani L, et al. Proc. Natl Acad. Sci. USA (2013) cited as Ref 613 in DOI: 10.1038/s41392-020-0110-5: Title
  11. Kieran MW, et al. Neuro Oncol. (2017) cited as Ref 612 in DOI: 10.1038/s41392-020-0110-5: Title
  12. Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5: Title
  13. Kaye SB, et al. Clin. Cancer Res. (2012) cited as Ref 610 in DOI: 10.1038/s41392-020-0110-5: Title
  14. Houot R, et al. Ann. Oncol. (2016) cited as Ref 609 in DOI: 10.1038/s41392-020-0110-5: Title
  15. Italiano A, et al. Ann. Oncol. (2013) cited as Ref 608 in DOI: 10.1038/s41392-020-0110-5: Title
  16. Catenacci DV, et al. J. Clin. Oncol. (2015) cited as Ref 607 in DOI: 10.1038/s41392-020-0110-5: Title
  17. Berlin J, et al. Clin. Cancer Res. (2013) cited as Ref 606 in DOI: 10.1038/s41392-020-0110-5: Title
  18. Gajjar A, et al. Clin. Cancer Res. (2013) cited as Ref 605 in DOI: 10.1038/s41392-020-0110-5: Title
  19. Robinson GW, et al. J. Clin. Oncol. (2015) cited as Ref 604 in DOI: 10.1038/s41392-020-0110-5: Title
  20. Zito PM, et al. () cited as Ref 603 in DOI: 10.1038/s41392-020-0110-5: Title
  21. Scales SJ, et al. Trends Pharmacol. Sci. (2009) cited as Ref 602 in DOI: 10.1038/s41392-020-0110-5: Title
  22. Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5: Title
  23. Dummer R, et al. J. Am. Acad. Dermatol (2016) cited as Ref 600 in DOI: 10.1038/s41392-020-0110-5: Title
  24. Sekulic A, et al. N. Engl. J. Med. (2012) cited as Ref 599 in DOI: 10.1038/s41392-020-0110-5: Title
  25. Thayer SP, et al. Nature (2003) cited as Ref 598 in DOI: 10.1038/s41392-020-0110-5: Title
  26. Yuan Z, et al. Oncogene (2007) cited as Ref 597 in DOI: 10.1038/s41392-020-0110-5: Title
  27. Mukherjee S, et al. Cancer Biol. Ther. (2006) cited as Ref 596 in DOI: 10.1038/s41392-020-0110-5: Title
  28. Smith DC, et al. Clin. Cancer Res. (2014) cited as Ref 595 in DOI: 10.1038/s41392-020-0110-5: Title
  29. Yang J, et al. J. Cell. Mol. Med. (2019) cited as Ref 594 in DOI: 10.1038/s41392-020-0110-5: Title
  30. Papayannidis C, et al. Blood Cancer J. (2015) cited as Ref 593 in DOI: 10.1038/s41392-020-0110-5: Title
  31. Messersmith WA, et al. Clin. Cancer Res. (2015) cited as Ref 592 in DOI: 10.1038/s41392-020-0110-5: Title
  32. Kummar S, et al. J. Clin. Oncol. (2017) cited as Ref 591 in DOI: 10.1038/s41392-020-0110-5: Title
  33. LoConte NK, et al. Invest. N. Drugs (2015) cited as Ref 590 in DOI: 10.1038/s41392-020-0110-5: Title
  34. Sahebjam S, et al. Br. J. Cancer (2013) cited as Ref 589 in DOI: 10.1038/s41392-020-0110-5: Title
  35. Richter S, et al. Invest N. Drugs (2014) cited as Ref 588 in DOI: 10.1038/s41392-020-0110-5: Title
  36. Diaz-Padilla I, et al. Gynecol. Oncol. (2015) cited as Ref 587 in DOI: 10.1038/s41392-020-0110-5: Title
  37. De Jesus-Acosta A, et al. Invest. N. Drugs (2014) cited as Ref 586 in DOI: 10.1038/s41392-020-0110-5: Title
  38. Strosberg JR, et al. Eur. J. Cancer (2012) cited as Ref 585 in DOI: 10.1038/s41392-020-0110-5: Title
  39. Tolcher AW, et al. J. Clin. Oncol. (2012) cited as Ref 584 in DOI: 10.1038/s41392-020-0110-5: Title
  40. Luistro L, et al. Cancer Res. (2009) cited as Ref 583 in DOI: 10.1038/s41392-020-0110-5: Title
  41. Zhang S, et al. Cancer Biol. Ther. (2014) cited as Ref 582 in DOI: 10.1038/s41392-020-0110-5: Title
  42. Brana I, et al. Br. J. Cancer (2014) cited as Ref 581 in DOI: 10.1038/s41392-020-0110-5: Title
  43. Cook N, et al. Br. J. Cancer (2018) cited as Ref 580 in DOI: 10.1038/s41392-020-0110-5: Title
  44. Schott AF, et al. Clin. Cancer Res. (2013) cited as Ref 579 in DOI: 10.1038/s41392-020-0110-5: Title
  45. Chen X, et al. Gynecol. Oncol. (2016) cited as Ref 578 in DOI: 10.1038/s41392-020-0110-5: Title
  46. Hoffman LM, et al. Childs Nerv. Syst. (2015) cited as Ref 577 in DOI: 10.1038/s41392-020-0110-5: Title
  47. Krop I, et al. J. Clin. Oncol. (2012) cited as Ref 576 in DOI: 10.1038/s41392-020-0110-5: Title
  48. Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5: Title
  49. Hayakawa Y, et al. Gastroenterology (2019) cited as Ref 574 in DOI: 10.1038/s41392-020-0110-5: Title
  50. Mamidi A, et al. Nature (2018) cited as Ref 573 in DOI: 10.1038/s41392-020-0110-5: Title

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:EntityUsage/Q8449"